Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-09

Clinical Trial Update: Evaluation of Curcumin's Effect on Inflammation in Hemodialysis Patients [NA]

View source ↗

Summary

A completed clinical trial evaluated whether curcumin reduces inflammation in patients undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Hemodialysis Complication, Hemodialysis-Induced Symptom | NA | Status: COMPLETED